Cyanotech CORP 10-Q quarterly reports

Cyanotech Corporation reported a significant turnaround in its second fiscal quarter, achieving near break-even net income driven by strong sales growth and improved gross margins, despite ongoing liquidity concerns.

Cyanotech Corporation reported a reduced net loss and improved gross margin for Q1 FY26, but faces significant liquidity challenges and a going concern warning.

Cyanotech reports a 10.6% increase in net sales for Q3 2025, with reduced operating losses compared to the previous year.

Cyanotech Corporation reported a decrease in second-quarter sales and gross profit, while experiencing a slight increase in sales for the first six months of fiscal year 2025, as the company navigates inventory restocking and demand fluctuations.

Cyanotech's first quarter of fiscal year 2025 saw a 15% increase in net sales compared to the same period last year, primarily driven by increased demand for astaxanthin products, though gross profit declined due to higher production costs.

Cyanotech reported a decrease in net sales for both the third quarter and first nine months of fiscal year 2024, driven by lower bulk sales and macroeconomic pressures.